Back to search

Netherlands· NL-7a1949b338c0

Mivacron, oplossing voor injectie 2 mg/ml

A mivacurium chloride product containing mivacuriumdichloride, registered in Netherlands by Aspen Pharma Trading Limited. The same ATC class is registered in 8 of our 19 countries.

ATC M03AC10

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMivacron, oplossing voor injectie 2 m…ATCM03AC10REGISTER NO.NL-7a1949b338c0PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Mivacurium chloride is registered in 8 of 19 countries.

Countries holding a registration under ATC M03AC10 (mivacurium chloride), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose

Mivacurium chloride · ATC M03AC10

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
MIVACURIUMDICHLORIDE
Manufacturer
Aspen Pharma Trading Limited
Country
Netherlands (NL)
ATC code
M03AC10
ATC class
Mivacurium chloride
Defined daily dose
14 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    16146

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

76 interactions on record for mivacurium chloride.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Mivacurium chloride · interactions on record

76 records

  • 12 severe
  • 60 moderate
  • 4 minor

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • ParomomycinA07AA06severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Mivacurium chloride in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mivacurium chloride products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Austria · Mivacron
  • Germany · Mivacurium Kalceks
  • Latvia · Mivacurium Kalceks
  • Malta · Mivacron
  • Poland · Mivacron, Mivacurium Kalceks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/933ae6fd-c11e-4d60-b19d-c209e2fb74b2
GET /v1/drugs/933ae6fd-c11e-4d60-b19d-c209e2fb74b2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h16146_smpc.pdf",
  "strength": null,
  "atc_label": "Mivacurium Chloride",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg16146",
  "excipients": [
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "MIVACURIUMDICHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h16146.pdf",
  "authorised_at": "1994/08/02",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "16146",
  "additional_monitoring": "N"
}

See everything about mivacurium chloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.